CDH2 and neoplasm: Differential expression analysis of tumor cells, identified using the “FindMarkers” function, revealed that CDH2 was significantly upregulated in the resistant group (expressed in 22.6% of cells), whereas its expression was low or undetectable in the sensitive group (p = 0.00087) (Figure 6D).